BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the...
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
01.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders. |
---|---|
AbstractList | The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders. |
Author | ALHASSAN, Abdul-Basit CAI, Jiaqiang WU, Hao YANG, Chundao LIU, Shilan LIU, Jian YU, Wensheng GAO, Xiaolei WANG, Jyhshing KOZLOWSKI, Joseph, A WANG, Dahai GUIADEEN, Deodialsingh BOGA, Sobhana Babu |
Author_xml | – fullname: WANG, Dahai – fullname: WU, Hao – fullname: LIU, Shilan – fullname: WANG, Jyhshing – fullname: KOZLOWSKI, Joseph, A – fullname: GUIADEEN, Deodialsingh – fullname: LIU, Jian – fullname: BOGA, Sobhana Babu – fullname: CAI, Jiaqiang – fullname: ALHASSAN, Abdul-Basit – fullname: YANG, Chundao – fullname: YU, Wensheng – fullname: GAO, Xiaolei |
BookMark | eNrjYmDJy89L5WTQcHL1i3L09XRxVfAEko5R_gGRQY5Rnn6uCk4h3gqefh6eTp4h_kHBPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2MjEwNTcyMnQmAglAMQbJa8 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEURS DE LA BTK DE TYPE BENZAMIDE IMIDAZOPYRAZINES BENZAMIDIMIDAZOPYRAZIN-BTK-HEMMER |
ExternalDocumentID | EP3240572B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3240572B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:00:14 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3240572B13 |
Notes | Application Number: EP20150875975 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&CC=EP&NR=3240572B1 |
ParticipantIDs | epo_espacenet_EP3240572B1 |
PublicationCentury | 2000 |
PublicationDate | 20231101 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 20231101 day: 01 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | Merck Sharp & Dohme LLC |
RelatedCompanies_xml | – name: Merck Sharp & Dohme LLC |
Score | 3.498272 |
Snippet | The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | BENZAMIDE IMIDAZOPYRAZINE BTK INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231101&DB=EPODOC&locale=&CC=EP&NR=3240572B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU2yNE9KSjTQBVa-promhgbALJVsmaKblAysXSySk0yAWQq02sLPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwMYKMImpuTjZugb4u_g7qzk7A1lqfkG2oHPnTM2NnIAdJVZgK9oclBlcw5xAm1IKkGsUN0EGtgCgYXklQgxMqXnCDJzOsIvXhBk4fKHz3UAmNOsVizBoOLn6RTn6erq4KgDLGxfHKP-AyCDHKE8_VwWnEG8FTz8PTyfPEP-gYFEGBTfXEGcPXaCV8XDvxbsGwB1nLMbAAuz1p0owKBhZWhhZmgF7QylpJuBTyCxTU1JMLdJSTcBXgxlLMkjiNEYKj5w0AxconCDb6WQYWEqKSlNlgfVqSZIcOEQAe5930w |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JT4NAFH5pqrHetGqsKwdDvBArhQIHYliGgC1LEE3thXRgmvRSG4vx7_sYafWit8lM8mbJfPPmm3kLwA2jhkbprC-h8lUl5b6PkCqMUqIFahe9oApCqra2iIb-s_I4USctWGx8YXic0E8eHBERVSDeK35er34esVxuW7m-owusenvwMtMVG3aMlxXcYqJrmySJ3dgRHQdLYpSaddw5VZNtJEo7eMPWajCQF7t2Sln91ijeAewmKGxZHUKLLbvQcTaJ17qwFzb_3VhsoLc-glubRFMrDFwi4HnjWtM4eU2taRARwc5GQhD5gR1kcfp0DIJHMseXsMt8O72cJNvBDU6gjayfnYIgG7psDJENlXOFRyEzWFmq-pwpPDXYoAe9P8Wc_dN2DR0_C8f5OIhG57Bfr9m3a90FtKv3D3aJOraiV3x1vgBFVXrG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BENZAMIDE+IMIDAZOPYRAZINE+BTK+INHIBITORS&rft.inventor=WANG%2C+Dahai&rft.inventor=WU%2C+Hao&rft.inventor=LIU%2C+Shilan&rft.inventor=WANG%2C+Jyhshing&rft.inventor=KOZLOWSKI%2C+Joseph%2C+A&rft.inventor=GUIADEEN%2C+Deodialsingh&rft.inventor=LIU%2C+Jian&rft.inventor=BOGA%2C+Sobhana+Babu&rft.inventor=CAI%2C+Jiaqiang&rft.inventor=ALHASSAN%2C+Abdul-Basit&rft.inventor=YANG%2C+Chundao&rft.inventor=YU%2C+Wensheng&rft.inventor=GAO%2C+Xiaolei&rft.date=2023-11-01&rft.externalDBID=B1&rft.externalDocID=EP3240572B1 |